More recently, the SUMMIT trial demonstrated that tirzepatide reduced the composite risk of cardiovascular death or worsening heart failure by 38% (HR = 0.62, 95% CI: 0.410.95) in patients with heart failure with preserved ejection fraction (HFpEF) and a BMI 30 kg/m 2 , 32% of whom also had type 2 diabetes
While there is no evidence that semaglutide causes thyroid nodules to grow or become malignant in humans, baseline thyroid imaging and periodic monitoring may be recommended for patients with known nodular disease
The results from the group are as followed: STEP 1: The mean change in body weight for those taking the semaglutide from the baseline was 14.9% over 68 weeks compared to a 2.4% decrease for those taking the placebo
I already have thyroid problems,'" she explained on the May 13 episode of The Kelly Clarkson Show
So yeah, that's my answer
Differential induction of glutathione S-transferase in rat aorta versus liver [PMID: 8204108] Laboratory literature summary: Differential induction of glutathione S-transferase in rat aorta versus liver